Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109535006B reveals a streamlined 2-step route to Cinacalcet HCl via a bromo-amine intermediate, offering high purity and industrial scalability for API manufacturers.
Novel patent CN119504447A details high-purity Bromhexine Hydrochloride synthesis avoiding expensive amines ensuring supply chain stability and cost efficiency for pharmaceutical manufacturers globally.
Patent CN110669027B discloses efficient synthesis of tetrahydrofuran carboxylic acid intermediates for prostate cancer drugs, offering scalable routes and reduced purification costs.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN105646618B reveals tin-catalyzed reduction amination for Gamithromycin. Offers safer conditions and reduced boron waste for supply chain efficiency.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN105001169A reveals a copper-catalyzed route for high-purity 3-aminoquinoxaline-2(1H)-one. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel one-pot synthesis for neuraminidase inhibitors using acetic acid catalyst. Enhances yield and purity for pharmaceutical supply chains.
Novel synthetic route for Edoxaban intermediates avoids sodium azide. Enhances safety and yield for pharmaceutical manufacturing supply chains.
Patent CN108276233A reveals a novel iron-catalyzed amide synthesis route offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102020606B details a mild synthesis for nitropyridine compounds. Discover cost-effective routes for pharmaceutical intermediates with improved safety.
Patent CN101531628B reveals a scalable one-pot hydrogenation route for 4-dimethylaminopiperidine hydrochloride, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN1027588C details novel CNS-active derivatives. Efficient reductive amination routes offer cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN101072746B details a cost-effective copper-catalyzed amination process for producing high-purity ortho-alkyl substituted anilines, essential for fungicide intermediates.
Patent CN101072746B details a copper-catalyzed amination process for ortho-alkyl halobenzenes, offering high yields and cost-effective manufacturing for fungicide intermediates.
Patent CN101072746B details a high-yield copper-catalyzed process for ortho-alkyl anilines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical manufacturing.
Patent CN114075153A details a high-yield, two-step Pd-catalyzed route for Vortioxetine impurity reference standards, ensuring superior purity and supply chain stability.
Patent CN114105780A details a cost-effective one-pot synthesis of isooctylamine from n-butyraldehyde using skeletal nickel, offering significant supply chain advantages.
Discover the advanced synthesis of N-[3-nitro-4-methyl-phenyl]-4-aldehyde-benzamide via patent CN101654416B. A cost-effective route for kinase inhibitor intermediates ensuring supply chain stability.
Patent CN103613602B reveals novel gambogic acid derivatives with enhanced solubility. Discover supply chain advantages and scalable synthesis for pharmaceutical intermediates.